Status:

COMPLETED

Postbariatric EArly Discharge Controlled by Healthdot

Lead Sponsor:

Philips Electronics Nederland B.V. acting through Philips CTO organization

Conditions:

Bariatric Surgery Candidate

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This clinical investigation is a single center patient preference trial in a tertiary hospital in the Netherlands, designed to compare the outcome of two different recovery paths after standard of car...

Eligibility Criteria

Inclusion

  • Adult (equal or above 18)
  • Approval for primary bariatric surgery (gastric sleeve or bypass) by a multidisciplinary bariatric team
  • Willing and able to sign informed consent form
  • Able to understand instructions
  • In possession of a telephone on which patient can be reached for the duration of participation (day 1-8)
  • An adult person must be present at the same location as the patient during the first night following surgery who is able to mobilize help or seek medical care if necessary.

Exclusion

  • Patients of psychiatric wards, inmates of prisons, or other state institutions
  • Investigator or any other team member involved directly or indirectly in the conduct of the clinical study
  • Any skin condition, for example prior rash, discoloration, scars or open wounds at the area (Left lower rib) where the Healthdot needs to be placed
  • Known allergy for the tissue adhesive used in the Healthdot (white band-aid)
  • Use of topical that is known to influence the skin at the test area (such as medical and non-medical creams or lotions)
  • Patient with active implantables such as Implantable Cardioverter Defibrilator (ICD) and pacemaker
  • Expected participation less than 8 days
  • Left lower rib (place where Healthdot will be applied) is involved in the area of surgery, area of disinfection or area where bandages are needed.
  • Patients with antibiotic resitant infections (e.g. MRSA)

Key Trial Info

Start Date :

February 22 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 25 2021

Estimated Enrollment :

208 Patients enrolled

Trial Details

Trial ID

NCT04754893

Start Date

February 22 2021

End Date

December 25 2021

Last Update

June 30 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Catharina Hospital

Eindhoven, North Brabant, Netherlands, 5623 EJ